Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 83

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 83
---
 and healthcare providers. Consequently,
the rate of disputes is expected to decrease. The provisions under the Bill would require healthcare providers to compensate patients
in a timely manner, sometimes without requiring proof of wrongdoing. The Bill also contemplates setting up a patient protection fund
for damages to patients pursuant to which healthcare providers have to make mandatory contributions according to the rules determined
by a patient protection committee. Failure by it to comply with applicable rules and regulations could result in penalties, the loss
of regulatory permits and damage to NewGenIvf’s business reputation, each of which could have a material adverse effect on its
financial condition and results of operations.

Furthermore, the Protection of A Child
Born By Medically Assisted Reproductive Technology Act B.E. 2558 (2015) of Thailand was promulgated with the intention to appropriately
designate the legitimate parenthood status of a child born using medically assisted reproductive technology and regulate any medical
scientific research on embryology and medically assisted reproductive technologies to prevent the misuse of medically assisted reproductive
technologies. NewGenIvf is therefore under the supervision of a Committee of the Protection for Children Born through Medically Assisted
Reproductive Technology, which is a committee established to control, inspect, supervise and formulate various policies relating to such
acts. In Cambodia and Kyrgyzstan, all health establishments, including private medical clinics, are under the supervision of the Cambodia
MOH and the Ministry of Health of Kyrgyzstan, respectively, which each governs and regulates the operation of medical clinics and activities
of medical practitioners in respective countries. In particular, the Medical Council of Cambodia, Cambodian Council of Nurses, Cambodian
Midwives Council and The Pharmaceutical Council of Cambodia, all assist the Cambodia MOH to supervise and monitor the practice of health
professionals in Cambodia. IVF/embryo implant/transfer activities are subject to an approval by the Cambodia MOH.

| ● | Privacy and Security                                                                                                                         
 Requirements. There are numerous laws and regulations related to the privacy and security of health information in each country.             
 In particular, regulations promulgated pursuant to the Personal Data Protection Act B.E. 2562 (2019) of Thailand (“PDPA”),                   
 Law on Data of Personal Character of April 14, 2008 No. 58 of Kyrgyzstan (“Data Protection Law”), as well as Regulation                      
 of Registration of Personal Data Holders (Owners) approved by the Resolution of the Cabinet of Ministers of KR of November 18,               
 202